1. Home
  2. OPAD vs CTSO Comparison

OPAD vs CTSO Comparison

Compare OPAD & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OPAD

Offerpad Solutions Inc.

HOLD

Current Price

$0.64

Market Cap

38.3M

Sector

Finance

ML Signal

HOLD

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.50

Market Cap

39.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPAD
CTSO
Founded
2015
1997
Country
United States
United States
Employees
140
N/A
Industry
Real Estate
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.3M
39.5M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
OPAD
CTSO
Price
$0.64
$0.50
Analyst Decision
Buy
Buy
Analyst Count
4
2
Target Price
$1.83
$5.38
AVG Volume (30 Days)
632.3K
61.5K
Earning Date
04-30-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
65.79
EPS
N/A
N/A
Revenue
N/A
$22,503,908.00
Revenue This Year
N/A
$10.34
Revenue Next Year
$32.08
$22.41
P/E Ratio
N/A
N/A
Revenue Growth
N/A
48.53
52 Week Low
$0.57
$0.50
52 Week High
$6.35
$1.39

Technical Indicators

Market Signals
Indicator
OPAD
CTSO
Relative Strength Index (RSI) 37.33 33.21
Support Level $0.57 $0.50
Resistance Level $0.90 $0.74
Average True Range (ATR) 0.06 0.04
MACD -0.01 -0.01
Stochastic Oscillator 12.88 4.99

Price Performance

Historical Comparison
OPAD
CTSO

About OPAD Offerpad Solutions Inc.

Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services, including mortgage, listing, renovation, and buyer representation services.

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Share on Social Networks: